Although previous studies have shown that SPOP promotes tumor progression by activating the β-catenin/TCF4 complex in clear cell renal cell carcinoma [35], we found that SPOP inhibits CRC progression by degrading β-catenin. This evidence concerns the gene TCF4 and clear cell renal carcinoma.